Cervical Cord Atrophy and Long-Term Disease Progression in Patients with Primary-Progressive Multiple Sclerosis

References

1. 1.↵
   2. Thompson AJ,
   3. Polman CH,
   4. Miller DH, et al

   . Primary progressive multiple sclerosis. Brain 1997;120:1085–96 doi:10.1093/brain/120.6.1085 pmid:9217691

   CrossRefPubMedWeb of Science
2. 2.↵
   2. Thompson AJ,
   3. Montalban X,
   4. Barkhof F, et al

   . Diagnostic criteria for primary progressive multiple sclerosis: a position paper. Ann Neurol 2000;47:831–35 pmid:10852554

   CrossRefPubMedWeb of Science
3. 3.↵
   2. Bjartmar C,
   3. Kidd G,
   4. Mörk S, et al

   . Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients. Ann Neurol 2000;48:893–901 pmid:11117546

   CrossRefPubMedWeb of Science
4. 4.↵
   2. Nijeholt GJ,
   3. van Walderveen MA,
   4. Castelijns JA, et al

   . Brain and spinal cord abnormalities in multiple sclerosis: correlation between MRI parameters, clinical subtypes and symptoms. Brain 1998;121:687–97 doi:10.1093/brain/121.4.687 pmid:9577394

   CrossRefPubMedWeb of Science
5. 5.↵
   2. Zivadinov R,
   3. Banas AC,
   4. Yella V, et al

   . Comparison of three different methods for measurement of cervical cord atrophy in multiple sclerosis. AJNR Am J Neuroradiol 2008;29:319–25 doi:10.3174/ajnr.A0813 pmid:17974604

   Abstract/FREE Full Text
6. 6.↵
   2. Ingle GT,
   3. Stevenson VL,
   4. Miller DH, et al

   . Primary progressive multiple sclerosis: a 5-year clinical and MR study. Brain 2003;126:2528–36 doi:10.1093/brain/awg261 pmid:12902314

   CrossRefPubMedWeb of Science
7. 7.↵
   2. Stevenson VL,
   3. Ingle GT,
   4. Miller DH, et al

   . Magnetic resonance imaging predictors of disability in primary progressive multiple sclerosis: a 5-year study. Mult Scler 2004;10:398–401 doi:10.1191/1352458504ms1055oa pmid:15327036

   CrossRefPubMedWeb of Science
8. 8.↵
   2. Agosta F,
   3. Absinta M,
   4. Sormani MP, et al

   . In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study. Brain 2007;130:2211–19 doi:10.1093/brain/awm110 pmid:17535835

   CrossRefPubMedWeb of Science
9. 9.↵
   2. Lukas C,
   3. Knol DL,
   4. Sombekke MH, et al

   . Cervical spinal cord volume loss is related to clinical disability progression in multiple sclerosis. J Neurol Neurosurg Psychiatry 2015;86:410–18 doi:10.1136/jnnp-2014-308021 pmid:24973341

   Abstract/FREE Full Text
10. 10.↵
    2. Losseff NA,
    3. Webb SL,
    4. O'Riordan JI, et al

    . Spinal cord atrophy and disability in multiple sclerosis: a new reproducible and sensitive MRI method with potential to monitor disease progression. Brain 1996;119:701–08 doi:10.1093/brain/119.3.701 pmid:8673483

    CrossRefPubMedWeb of Science
11. 11.↵
    2. Rocca MA,
    3. Horsfield MA,
    4. Sala S, et al

    . A multicenter assessment of cervical cord atrophy among MS clinical phenotypes. Neurology 2011;76:2096–102 doi:10.1212/WNL.0b013e31821f46b8 pmid:21670439

    Abstract/FREE Full Text
12. 12.↵
    2. Lukas C,
    3. Sombekke MH,
    4. Bellenberg B, et al

    . Relevance of spinal cord abnormalities to clinical disability in multiple sclerosis: MR imaging findings in a large cohort of patients. Radiology 2013;269:542–52 doi:10.1148/radiol.13122566 pmid:23737540

    CrossRefPubMed
13. 13.↵
    2. Furby J,
    3. Hayton T,
    4. Altmann D, et al

    . A longitudinal study of MRI-detected atrophy in secondary progressive multiple sclerosis. J Neurol 2010;257:1508–16 doi:10.1007/s00415-010-5563-y pmid:20437181

    CrossRefPubMedWeb of Science
14. 14.↵
    2. Sastre-Garriga J,
    3. Ingle GT,
    4. Rovaris M, et al

    . Long-term clinical outcome of primary progressive MS: predictive value of clinical and MRI data. Neurology 2005;65:633–35 doi:10.1212/01.wnl.0000173061.12776.1f pmid:16116134

    Abstract/FREE Full Text
15. 15.↵
    2. Stevenson VL,
    3. Miller DH,
    4. Leary SM, et al

    . One year follow up study of primary and transitional progressive multiple sclerosis. J Neurol Neurosurg Psychiatry 2000;68:713–18 doi:10.1136/jnnp.68.6.713 pmid:10811693

    Abstract/FREE Full Text
16. 16.↵
    2. Cawley N,
    3. Tur C,
    4. Prados F, et al

    . Spinal cord atrophy as a primary outcome measure in Phase II trials of progressive multiple sclerosis. Mult Scler 2017 May 1. [Epub ahead of print] doi:10.1177/1352458517709954 pmid:28516804

    CrossRefPubMed
17. 17.↵
    2. Valsasina P,
    3. Rocca MA,
    4. Horsfield MA, et al

    . A longitudinal MRI study of cervical cord atrophy in multiple sclerosis. J Neurol 2015;262:1622–28 doi:10.1007/s00415-015-7754-z pmid:25929665

    CrossRefPubMed
18. 18.↵
    2. Horsfield MA,
    3. Sala S,
    4. Neema M, et al

    . Rapid semi-automatic segmentation of the spinal cord from magnetic resonance images: application in multiple sclerosis. Neuroimage 2010;50:446–55 doi:10.1016/j.neuroimage.2009.12.121 pmid:20060481

    CrossRefPubMedWeb of Science
19. 19.↵
    2. Kearney H,
    3. Yiannakas MC,
    4. Abdel-Aziz K, et al

    . Improved MRI quantification of spinal cord atrophy in multiple sclerosis. J Magn Reson Imaging 2014;39:617–23 doi:10.1002/jmri.24194 pmid:23633384

    CrossRefPubMed
20. 20.↵
    2. Montalban X,
    3. Sastre-Garriga J,
    4. Tintoré M, et al

    . A single-center, randomized, double-blind, placebo-controlled study of interferon beta-1b on primary progressive and transitional multiple sclerosis. Mult Scler 2009;15:1195–205 doi:10.1177/1352458509106937 pmid:19797261

    CrossRefPubMed
21. 21.↵
    2. Lin X,
    3. Tench CR,
    4. Turner B, et al

    . Spinal cord atrophy and disability in multiple sclerosis over four years: application of a reproducible automated technique in monitoring disease progression in a cohort of the interferon beta-1a (Rebif) treatment trial. J Neurol Neurosurg Psychiatry 2003;74:1090–94 doi:10.1136/jnnp.74.8.1090 pmid:12876240

    Abstract/FREE Full Text
22. 22.↵
    2. Rashid W,
    3. Davies GR,
    4. Chard DT, et al

    . Increasing cord atrophy in early relapsing-remitting multiple sclerosis: a 3 year study. J Neurol Neurosurg Psychiatry 2006;77:51–55 doi:10.1136/jnnp.2005.068338 pmid:16361592

    Abstract/FREE Full Text
23. 23.↵
    2. Plummer DL

    . Dispimage: a display and analysis tool for medical images. Riv Neuroradiol 1992;19:1715–20
24. 24.↵
    2. Aymerich FX,
    3. Sobrevilla P,
    4. Montseny E, et al

    . Fuzzy approach to lesion load measurement in T1-weighted images. Mult Scler 2001;7(suppl 1):87
25. 25.↵
    2. Aymerich X,
    3. Sobrevilla P,
    4. Montseny E, et al

    . Application of an automatic segmentation algorithm to brain atrophy assessment in multiple sclerosis. Rev Neurol (Paris) 2000;156(suppl 3):103–04
26. 26.↵
    2. Evans JD

    . Straightforward Statistics for Behavioral Sciences. Pacific Grove: Brooks/Cole Publishing; 1996
27. 27.↵
    2. Twisk JW

    . Applied Longitudinal Data Analysis for Epidemiology: A Practical Guide. New York: Cambridge University Press; 2013
28. 28.↵
    2. Rovaris M,
    3. Judica E,
    4. Sastre-Garriga J, et al

    . Large-scale, multicentre, quantitative MRI study of brain and cord damage in primary progressive multiple sclerosis. Mult Scler 2008;14:455–64 doi:10.1177/1352458507085129 pmid:18208869

    CrossRefPubMedWeb of Science